Page 1: Executive Summary

Introduction

Page 2: Classification of anti infective pharmaceutical market

Page 3: Types of anti infective drugs

Market Overview

Page 4: Global Anti-Infective Pharmaceuticals Market - Overview, Size & Growth (Value: 2010-15e),

Page 5: Indian Anti-Infective Pharmaceuticals Market- Overview, Size & Growth (Value: 2010-2015e), Growth in Therapeutic segments

Drivers & Challenges

Page 6: Summary

Page 7-10: Drivers

Page 11: Challenges

Government initiatives

Page 12: Summary

Page 13-20: Government Initiatives

Drug regulation and patents

Page 21: Phases of clinical trials

Page 22-23: Drug regulations

Page 24-26: List of patent approvals

Competition

Page 27-35: Major domestic players

Page 36-43: Major foreign players

Page 44: Recent Developments

Strategic recommendation

Page 45: Strategic Recommendations

Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian market is characterized by a huge demand for anti-infective drugs. It is a highly fragmented market with a large number of foreign and domestic players. The huge increase in the patient population, increasing number of vaccine approvals, increase in health insurances and introduction of newer and better drugs is helping the market to grow. The Indian Government, on its part, has introduced some control programmes, undertaken various Private Partnership Projects (PPP) and has taken initiatives to reduce drug prices. The market is expected to exhibit steady growth over the next few years.

The report begins with the introduction section which offers a brief classification of the anti infectives market. It then moves to the market overview section which provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth.

An analysis of the drivers explains the factors for growth of the industry including increasing patient population, increasing vaccine approvals, increase in health insurances and introduction of newer and better drugs. The key challenges include pricing pressure and logistic problems in the vaccine market.

The government initiatives section gives a brief description of the different control programmes undertaken by the Government. It also analyses the efforts to reduce drug prices, changes in the customs duty structure and the various PPP projects undertaken by the Government.

A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for anti infective drugs.

The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry.